Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.51M Sell
27,275
-10,750
-28% -$1.26M 1.32% 33
2026
Q1
$4.56M Hold
38,025
2.12% 16
2025
Q4
$3.96M Hold
38,025
1.85% 16
2025
Q3
$3.19M Hold
38,025
1.48% 29
2025
Q2
$3.17M Buy
38,025
+7,180
+23% +$571K 1.53% 31
2025
Q1
$2.75M Buy
+30,845
New +$2.88M 1.41% 34

Other funds holding MRK

SSA Swiss Advisors's MRK Position: Q2 2026 in Review

SSA Swiss Advisors reduced its Merck (MRK) stake by 28% in Q2 2026, selling an estimated $1.26M and leaving 27,275 shares worth $3.51M. The position accounts for 1.32% of the portfolio, ranked #33.

SSA Swiss Advisors first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.56M in Q1 2026. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SSA Swiss Advisors held 27,275 shares of Merck worth $3.51M as of Q2 2026.
  • SSA Swiss Advisors sold 10,750 Merck shares in Q2 2026, an estimated $1.26M.
  • Merck made up 1.32% of SSA Swiss Advisors's portfolio in Q2 2026, its #33 holding.
  • SSA Swiss Advisors first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • SSA Swiss Advisors's Merck position peaked at $4.56M in Q1 2026.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.